Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 15/20 | 0.62 |
| ▸ | MTNR1B | P49286 | 15/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.60 |
| ▸ | BLM | P54132 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.56 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 1/20 | 0.56 |
| ▸ | SPR | P35270 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4501209 | 0.85 | MTNR1A (0.67) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL25842178 | 0.82 | HTR2A (0.42) | MTNR1AMTNR1BMEN1KMT2AHTR2B | |
| SCHEMBL16433255 | 0.82 | NPC1 (0.50) | MTNR1AMTNR1BMEN1KMT2ACYP2D6 | |
| SCHEMBL25260689 | 0.81 | HTR2A (0.57) | CYP1A2MEN1KMT2ATSHRCYP3A4 | |
| SCHEMBL29804890 | 0.81 | HTR2A (0.57) | CYP1A2MEN1KMT2ATSHRCYP3A4 | |
| SCHEMBL26202291 | 0.81 | MTNR1A (0.59) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL31549198 | 0.80 | ALDH1A1 (0.48) | MTNR1AMTNR1BMEN1KMT2ALMNA | |
| SCHEMBL29799289 | 0.80 | MTNR1A (0.61) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL25381364 | 0.80 | HTR2B (0.61) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL25383197 | 0.80 | MTNR1A (0.61) | MTNR1AMTNR1BCYP1A2BLMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219888-A1 | PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | MAGICMED INDUSTRIES INC. (CA) | 2023-07-13 | — | — | US | disclosed |
| US-20230219888-A1 | PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | MAGICMED INDUSTRIES INC. (CA) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219888-A1 | PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | AANAT, ACAT2, PCYT1A | MTNR1A 1294/4885MTNR1B 678/4885CYP1A2 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.